937814-45-4

Upstream product

• 937814-44-3 (2S,5R)-2-(3,4-difluorophenyl)-5-hydroxymethyl-pyrrolidine-1-carboxylic acid t-butyl ester 
• 5927-18-4 trimethyl phosphonoacetate 
• 937814-43-2 tert-butyl (2S,5R)-2-(3,4-difluorophenyl)-5-[(E)-2-methoxycarbonylvinyl]pyrrolidine-1-carboxylate 
• 1050394-01-8 (2R,5S)-5-(3,4-difluorophenyl)pyrrolidine-2-carboxylic acid ethyl ester 
• 1050393-98-0 (R)-5-(3,4-difluorophenyl)-3,4-dihydro-2H-pyrrole-2-carboxylic acid ethyl ester 
• 937814-40-9 (2R,5S)-5-(3,4-difluorophenyl)pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl ester 
• 937814-39-6 (R)-2-t-butoxycarbonylamino-5-oxo-5-(3,4-difluorophenyl)valeric acid ethyl ester 
• 348-61-8 1-bromo-3,4-difluorobenzene 
• 90897-92-0 3,4-difluorophenylmagnesium bromide 
• 144978-12-1 1-tert-butyl 2-ethyl (2R)-5-oxopyrrolidine-1,2-dicarboxylate 
• 68766-96-1 ethyl (R)-2-pyrrolidone-5-carboxylate 

Downstream Products

• 1050394-18-7 (2S,5R)-2-(3,4-difluorophenyl)-5-((S)-1-hydroxyethyl)-pyrrolidine-1-carboxylic acid t-butyl ester 
• 1050394-16-5 (2S,5R)-2-(3,4-difluorophenyl)-5-((R)-1-hydroxyethyl)-pyrrolidine-1-carboxylic acid t-butyl ester 

Relevant academic research and scientific papers

HETEROCYCLIC TYPE CINNAMIDE DERIVATIVE

Disclosed is a compound represented by the formula (I) below or a pharmacologically acceptable salt thereof. Also disclosed is a use of the compound or salt as a pharmaceutical product. (In the formula, Ar1 represents a triazolyl group or the l

TWO CYCLIC OXOMORPHORIN DERIVATIVES

The present invention relates to a compound represented by formula (I): wherein R1 represents a C1-3 alkyl group, R2 represents a hydrogen atom or a C1-3 alkyl group, Ar represents a phenyl group or the like which may be substituted with 1 to 3 substituents, X represents an oxygen atom or the like, n and m are the same or different and integers of 0 to 2, or a pharmacologically acceptable salt, and use thereof as a medicament.